Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer. RNA-Seq data for paired baseline and end of treatment samplesEGA dataset EGAD00001
This meta-analysis sought to assess the efficacy and safety of poly (adenosine diphosphate-ribose) polymerase inhibitors (PARPi) as maintenance therapy for patients with newly diagnosed advanced ovari
ObjectiveThe effects of PD-(L)1 inhibitors on immediate and long-term prognosis, solid tumor response, and adverse effects in the treatment of advanced gastroesophageal cancer were summarized and anal
Background: Recent phase II and III clinical trials demonstrated antitumor activity of eribulin, a tubulin-interacting cytotoxic agent, in patients with metastatic soft tissue sarcoma (STS). In this e